Clinical Trials Browser

Phase 2 × Cytomegalovirus Infections × 90 days × Clear all

NCT02210078 2026-02-17

Donor Cytomegalovirus-Specific Cytotoxic T-Lymphocytes in Treating Patients With a Persistent Cytomegalovirus Infection

Phase 2 Active not recruiting

Other hematologic neoplasm

Cytomegalovirus Infections, Hematologic Neoplasms